Display options
Cite
Dimmitt S, Stampfer H, Martin JH. When less is more - efficacy with less toxicity at the ED50. Br J Clin Pharmacol. 2017;83(7):1365-1368doi: 10.1111/bcp.13281.
Dimmitt, S., Stampfer, H., & Martin, J. H. (2017). When less is more - efficacy with less toxicity at the ED50. British journal of clinical pharmacology, 83(7), 1365-1368. https://doi.org/10.1111/bcp.13281
Dimmitt, Simon, et al. "When less is more - efficacy with less toxicity at the ED50." British journal of clinical pharmacology vol. 83,7 (2017): 1365-1368. doi: https://doi.org/10.1111/bcp.13281
Dimmitt S, Stampfer H, Martin JH. When less is more - efficacy with less toxicity at the ED50. Br J Clin Pharmacol. 2017 Jul;83(7):1365-1368. doi: 10.1111/bcp.13281. Epub 2017 Apr 06. PMID: 28387051; PMCID: PMC5465328.
Copy Download .nbib Format: NLM
Share it on

Br J Clin Pharmacol. 2017 Jul;83(7):1365-1368. doi: 10.1111/bcp.13281. Epub 2017 Apr 06.

When less is more - efficacy with less toxicity at the ED50.

British journal of clinical pharmacology

Simon Dimmitt, Hans Stampfer, Jennifer H Martin

Affiliations

  1. School of Medicine & Pharmacology, University of Western Australia, 3/10 McCourt St, West Leederville, 6007, Australia.
  2. Australian Community & Health Foundation, West Leederville, 6007, Australia.
  3. Joondalup Health Campus, The University of Western Australia, Crawley, WA, 6009, Australia.
  4. Consultant Psychiatrist, Sir Charles Gairdner Hospital, Perth, WA, Australia.
  5. University of Newcastle School of Medicine and Public Health, Callaghan, New South Wales, 2298, Australia.
  6. Department of Medicine, Hunter New England Local Health District, Newcastle, Australia.

PMID: 28387051 PMCID: PMC5465328 DOI: 10.1111/bcp.13281

[No abstract available.]

Keywords: dose-response; effective dose 50; pharmaceutical marketing

References

  1. N Engl J Med. 1998 Nov 5;339(19):1349-57 - PubMed
  2. Lancet. 2009 Nov 28;374(9704):1840-8 - PubMed
  3. Br J Clin Pharmacol. 2015 Oct;80(4):818-26 - PubMed
  4. N Engl J Med. 2007 Nov 22;357(21):2109-22 - PubMed
  5. Intern Med J. 2010 Jun;40(6):395-8 - PubMed
  6. N Engl J Med. 2008 Jun 12;358(24):2545-59 - PubMed
  7. JAMA. 2007 May 9;297(18):2018-24 - PubMed
  8. Lancet. 1994 Nov 19;344(8934):1383-9 - PubMed
  9. BMJ. 2008 Nov 11;337:a2423 - PubMed
  10. JAMA. 2004 Oct 13;292(14):1724-37 - PubMed
  11. Br J Clin Pharmacol. 2014 Aug;78(2):202-17 - PubMed
  12. Pharmacoepidemiol Drug Saf. 2002 Sep;11(6):439-46 - PubMed
  13. Br J Clin Pharmacol. 2017 Jul;83(7):1365-1368 - PubMed
  14. Br J Clin Pharmacol. 2016 Jul;82(1):168-77 - PubMed
  15. J Am Coll Cardiol. 2008 Oct 28;52(18):1482-9 - PubMed
  16. N Engl J Med. 2005 Apr 7;352(14):1425-35 - PubMed
  17. N Engl J Med. 1999 Sep 2;341(10):709-17 - PubMed
  18. Eur Heart J. 2015 Jul 21;36(28):1831-8 - PubMed
  19. Am J Psychiatry. 2004 May;161(5):826-35 - PubMed
  20. J Natl Cancer Inst. 2007 Aug 1;99(15):1148-50 - PubMed
  21. JAMA. 2003 Feb 19;289(7):871-8 - PubMed
  22. Br J Clin Pharmacol. 2014 Nov;78(5):1076-9 - PubMed
  23. Lancet. 1998 Sep 12;352(9131):854-65 - PubMed
  24. BMJ. 2003 Jun 28;326(7404):1423 - PubMed
  25. Heart. 2016 May;102(9):653-4 - PubMed
  26. Heart. 2007 Aug;93(8):914-21 - PubMed
  27. Circulation. 1999 Dec 7;100(23):2312-8 - PubMed
  28. Ann Fam Med. 2015 Jan-Feb;13(1):69-79 - PubMed

MeSH terms

Publication Types